Acquisition of additional 13.25% stake in Adcock Ingram Holdings Proprietary Limited. - Natco Pharma Ltd

Code BSE: 524816 NSE:

NATCO first acquired 35.75% in Adcock Ingram through its participation in the Adcock Ingram’s delisting process in 2025 following the announcement of a firm intention offer in July 2025, shareholder approval in October 2025 and completion of the transaction in November 2025.